Results 221 to 230 of about 79,311 (270)

Correction: Ziranu et al. Navigating the Landscape of Liquid Biopsy in Colorectal Cancer: Current Insights and Future Directions. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 7619. [PDF]

Int J Mol Sci
Ziranu P, Pretta A, Saba G, Spanu D, Donisi C, Ferrari PA, Cau F, D'Agata AP, Piras M, Mariani S, Puzzoni M, Pusceddu V, Coghe F, Faa G, Scartozzi M.   +14 more
europepmc   +1 more source

Issue Information

Exploration, Volume 6, Issue 2, April 2026.
wiley   +1 more source

NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial. [PDF]

Nat Commun
Gao C, Zhang Y, Qu X, Chen X, Zhang J, Wu H, Sun M, Zha Y, Wang J, Wang Y, Li Z, Gao J, Lin R, Zang A, Zhang H, Yuan X, Du C, Zhao J, Yang Y, Shi X, Cheng W, Wang B, Wu S, Zhao T, Wang J, Gao S, Wang X, Ma W, Liu R, Shi Y, Liu Y, Xie Y, Niu M, Zhao F, Yu J, Hao J.   +35 more
europepmc   +1 more source

Characterization of the anticancer effect of mebendazole and its interaction with standard cytotoxic drugs in patient tumor cells <i>ex vivo</i> and in an <i>in vivo</i> mouse model. [PDF]

Oncol Rep
Mansoori S, Blom K, Andersson C, Fryknäs M, Larsson R, Nygren P.   +5 more
europepmc   +1 more source

Comprehensive pharmacovigilance of phytoalkaloid chemotherapeutics: Signal detection and time-to-onset analysis based on FAERS. [PDF]

Medicine (Baltimore)
Song B, Zhang Y, Wang L, Hu J.
europepmc   +1 more source

Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938). [PDF]

Cancer
Villaruz LC, Jin J, Wang H, Lee JJ, Luke JJ, Rhee JC, Waqar SN, Shapiro GI, Cleary J, Davar D, Burns TF, Verma R, Amin M, Appleman L, Ciombor KK, Davis EJ, Riess JW, Dees EC, Kim EJ, Cardin D, Guo J, Christner SM, Deppas J, Parise AM, Schmitz JC, Guerrouahen BS, Suchko M, Contreras A, Li L, Ferry-Galow KV, Chang TC, Jiwani S, Bakkenist CJ, Chu E, Gore SD, Beumer JH.   +35 more
europepmc   +1 more source

Correction to "Antibiotics Improve the Treatment Efficacy of Oxaliplatin-Based but Not Irinotecan-Based Therapy in Advanced Colorectal Cancer Patients". [PDF]

J Oncol
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Irinotecan toxicity

Current Opinion in Supportive & Palliative Care, 2007
The toxicity of irinotecan is predictable, manageable and nonadditive in the majority of patients; however, with its increasing use alone and in combination with other agents and modalities, the recognition and control of these adverse effects remain a clinical challenge.
openaire   +2 more sources

Irinotecan

Reactions Weekly, 2021
openaire   +2 more sources